|
INO Inovio Pharmaceuticals Inc 1055726 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-19,682,798.00 |
| Balance Sheet |
|
Current Assets
|
$39,439,605.00 |
|
Assets
|
$49,777,142.00 |
|
Current Liabilities
|
$37,923,025.00 |
|
Liabilities
|
$43,709,260.00 |
|
Equity
|
$6,067,882.00 |
|
Shares Out
|
69773237.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-21,591,316.00 |
|
Investing Cash Flow
|
$2,635,857.00 |
| Market Analysis |
Market Cap
|
$46,050,336.42 |
|
Price
|
$0.70 |
|
BVPS
|
0.09 |
|
PB
|
7.33 |
|
EPS
|
-0.28 |
|
FCF
|
$-21,591,316.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:38 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:36 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-0.26 |
|
|
2026-05-13 |
-0.28 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.61 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-10 |
-0.87 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INO documents filed with the SEC.
INO Filings
Clear
